Microbicide development: multiple targets, multiple mechanisms

Por Shattock, Robin
Publicado em 2006

Microbicides: Topical Prevention against HIV

Por Shattock, Robin J., Rosenberg, Zeda
Publicado em 2012

Critical issues in mucosal immunity for HIV-1 vaccine development

Por Haynes, Barton F., Shattock, Robin J.
Publicado em 2008

High-mannose specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization

Por Hu, Qinxue, Mahmood, Naheed, Shattock, Robin J.
Publicado em 2007

Innate immunity against HIV: a priority target for HIV prevention research

Por Borrow, Persephone, Shattock, Robin J, Vyakarnam, Annapurna
Publicado em 2010

C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors

Por Hu, Qinxue, Huang, Xin, Shattock, Robin J.
Publicado em 2010

Role of Capsule and Interleukin-6 in Long-Term Immune Control of Cryptococcus neoformans Infection by Specifically Activated Human Peripheral Blood Mononuclear Cells

Por Siddiqui, Asna A., Shattock, Robin J., Harrison, Thomas S.
Publicado em 2006

Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?

Por Klasse, Per Johan, Shattock, Robin J, Moore, John P
Publicado em 2006

Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Por Grivel, Jean-Charles, Shattock, Robin J, Margolis, Leonid B
Publicado em 2011

Saquinavir Inhibits Early Events Associated with Establishment of HIV-1 Infection: Potential Role for Protease Inhibitors in Prevention

Por Stefanidou, Martha, Herrera, Carolina, Armanasco, Naomi, Shattock, Robin J.
Publicado em 2012

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice

Por Buffa, Viviana, Klein, Katja, Fischetti, Lucia, Shattock, Robin J.
Publicado em 2012

Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants

Por Fletcher, Patricia S, Wallace, Gregory S, Mesquita, Pedro MM, Shattock, Robin J
Publicado em 2006

Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide

Por Harman, Sarah, Herrera, Carolina, Armanasco, Naomi, Nuttall, Jeremy, Shattock, Robin J.
Publicado em 2012

Animal models for microbicide studies

Por Veazey, Ronald S., Shattock, Robin J, Klasse, Per Johan, Moore, John P.
Publicado em 2012

HIV-1 infection of human penile explant tissue and protection by candidate microbicides

Por Fischetti, Lucia, Barry, Sheila M., Hope, Thomas J., Shattock, Robin J.
Publicado no AIDS (2009)

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

Por Fletcher, Patricia, Herrera, Carolina, Armanasco, Naomi, Nuttall, Jeremy, Shattock, Robin J.
Publicado no AIDS Res Hum Retroviruses (2016)

Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity: A summary report from a Global HIV Vaccine Enterprise Working Group

Por Shattock, Robin J, Haynes, Barton F, Pulendran, Bali, Flores, Jorge, Esparza, José
Publicado em 2008

Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

Por Herrera, Carolina, Cranage, Martin, McGowan, Ian, Anton, Peter, Shattock, Robin J.
Publicado em 2009

Heterogeneous Conformation of HIV-1 Envelopes on Individual Virions

Por Arakelyan, Anush, King, Debbie, Grivel, Jean-Charled, Shattock, Robin J., Margolis, Leonid
Publicado no AIDS Res Hum Retroviruses (2014)

Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastoris

Por Aw, Rochelle, McKay, Paul F., Shattock, Robin J., Polizzi, Karen M.
Publicado no AMB Express (2017)